OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
paper
Cited
Public
Unavailable
- Authors
- Haerian, Batoul Sadat; Haerian, Monir Sadat
- Year
- 2013
- Journal
- Pharmacogenomics
- PMID
- 23651028
- DOI
- 10.2217/pgs.13.57
The OPRM1 gene encodes the Β΅-opioid receptor, which is the primary site of action of most opioids. Several studies and three meta-analyses have examined a possible link between the exonic OPRM1 A118G (rs1799971) polymorphism and opioid dependence; however, results have been inconclusive. Therefore, a systematic review and meta-analysis have been carried out to examine whether this polymorphism is associated with opioid dependence. Thirteen studies (n = 9385), comprising 4601 opioid dependents and 4784 controls, which evaluated association of the OPRM1 rs1799971 polymorphism with susceptibility to opioids, were included in this study. Our meta-analysis showed significant association between this polymorphism and susceptibility to opioid dependence in overall studies under a codominant model, as well as susceptibility to opioid dependence or heroin dependence in Asians under an autosomal dominant model. The nonsynonymous OPRM1 rs1799971 might be a risk factor for addiction to opioids or heroin in an Asian population.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2025 | β |
| Genetic and Epigenetic Approaches to Opioid Use Disorder. | Ranadeva ND et al. | β | 2025 | β |
| Association of OPRM1 rs1799971, HTR1B rs6296 and COMT rs4680 polymorphisms with clinical phenotype among women with fibromyalgia. | FernΓ‘ndez-de-Las-PeΓ±as C et al. | β | 2024 | β |
| Genetic Variants Linked to Opioid Addiction: A Genome-Wide Association Study. | Panday SK et al. | β | 2024 | β |
| Genome-wide association reveals a locus in neuregulin 3 associated with gabapentin efficacy in women with chronic pelvic pain. | Mackenzie SC et al. | β | 2024 | β |
| Genomic factors associated with substance use disorder relapse: A critical review. | Al-Marzooqi N et al. | β | 2024 | β |
| G protein-coupled receptor (GPCR) pharmacogenomics. | Thompson MD et al. | β | 2024 | β |
| Molecular and Environmental Determinants of Addictive Substances. | Lorek M et al. | β | 2024 | β |
| Allele frequency and genotype distribution of the opioid receptor ΞΌ-1 (OPRM1) A118G polymorphism in the Western Saudi population. | Bagher AM et al. | β | 2023 | β |
| Ethnicity-dependent effect of rs1799971 polymorphism on OPRM1 expression in the postmortem brain and responsiveness to antipsychotics. | Miyahara K et al. | β | 2023 | β |
| Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. | Muriel J et al. | β | 2023 | β |
| Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. | Xie X et al. | β | 2022 | β |
| Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor Β΅1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? | GondrΓ©-Lewis MC et al. | β | 2022 | β |
| Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical Data. | LeitΓ£o M et al. | β | 2022 | β |
| Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings. | Oswald LM et al. | β | 2021 | β |
| Epigenetic and Genetic Factors Associated With Opioid Use Disorder: Are These Relevant to African American Populations. | Blackwood CA et al. | β | 2021 | β |
| Genetic Vulnerability to Opioid Addiction. | Reed B et al. | β | 2021 | β |
| Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways. | Wu B et al. | β | 2021 | β |
| OPRM1 and CYP3A4 association with methadone dose in Iranian patients undergoing methadone maintenance therapy. | Akbari A et al. | β | 2021 | β |
| Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis. | Levran O et al. | β | 2021 | β |
| A novel theory on the predictive value of variation in the Ξ²-endorphin system on the risk and severity of PTSD. | Mac Gillavry DW et al. | β | 2020 | β |
| Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment. | Tolami HF et al. | β | 2020 | β |
| Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference. | Collins D et al. | β | 2020 | β |
| Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine. | Abijo T et al. | β | 2020 | β |
| Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas. | Eckardt P et al. | β | 2020 | β |
| Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. | Cornett EM et al. | β | 2020 | β |
| Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence. | Konjevod M et al. | β | 2020 | β |
| Associations among the opioid receptor gene (<i>OPRM1</i>) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study. | Kim KM et al. | β | 2019 | β |
| Current understanding of the neurobiology of opioid use disorder: An overview. | Moningka H et al. | β | 2019 | β |
| Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia. | Kaski SW et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review. | Wang SC et al. | β | 2019 | β |
| Pharmacogenetics of alcohol use disorder treatments: an update. | Hartwell EE et al. | β | 2019 | β |
| Sex differences in neural mechanisms mediating reward and addiction. | Becker JB et al. | β | 2019 | β |
| Single nucleotide polymorphism analysis in interstitial cystitis/painful bladder syndrome. | CassΓ£o VD et al. | β | 2019 | β |
| Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review. | Wang SC et al. | β | 2019 | β |
| A prospective, longitudinal study to evaluate the clinical utility of a predictive algorithm that detects risk of opioid use disorder. | Brenton A et al. | β | 2018 | β |
| Heroin-induced suppression of saccharin intake in OPRM1 A118G mice. | Freet CS et al. | β | 2018 | β |
| Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors. | Blum K et al. | β | 2018 | β |
| Molecular Genetics and New Medication Strategies for Opioid Addiction. | Hurd YL et al. | β | 2018 | β |
| Pharmacogenetics of Opioid Use and Implications for Pain Management. | Nerenz RD et al. | β | 2018 | β |
| Using stratified medicine to understand, diagnose, and treat neuropathic pain. | Themistocleous AC et al. | β | 2018 | β |
| A brief review of the genetics and pharmacogenetics of opioid use disorders. | Berrettini W | β | 2017 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2017 | β |
| Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome. | Wasilewski A et al. | β | 2017 | β |
| Convergent Balancing Selection on the Mu-Opioid Receptor in Primates. | Sweeney CG et al. | β | 2017 | β |
| Genetic Testing for Psychopharmacology: Is It Ready for Prime Time? | Leahy LG | β | 2017 | β |
| Genome-wide data from two early Neolithic East Asian individuals dating to 7700 years ago. | Siska V et al. | β | 2017 | β |
| Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder. | Brenton A et al. | β | 2017 | β |
| The ΞΌ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment. | Levran O et al. | β | 2017 | β |
| Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting. | Sharma M et al. | β | 2017 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| T394A Mutation at the ΞΌ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice. | Wang XF et al. | β | 2016 | β |
| [Biological basis of problematic internet use (PIN) and therapeutic implications]. | Bauernhofer K et al. | β | 2015 | β |
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | Hancock DB et al. | β | 2015 | β |
| Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. | Woodcock EA et al. | β | 2015 | β |
| Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"? | Carlier N et al. | β | 2015 | β |
| Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. | Connery HS | β | 2015 | β |
| Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice. | Zhang Y et al. | β | 2015 | β |
| Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism. | Robinson JE et al. | β | 2015 | β |
| [Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach]. | Krupitsky ΠΠ et al. | β | 2015 | β |
| The mu opioid receptor: A new target for cancer therapy? | Singleton PA et al. | β | 2015 | β |
| A psycho-genetic study of hedonic responsiveness in relation to "food addiction". | Davis C et al. | β | 2014 | β |
| Genetics of opiate addiction. | Reed B et al. | β | 2014 | β |
| MCPerm: a Monte Carlo permutation method for accurately correcting the multiple testing in a meta-analysis of genetic association studies. | Jiang Y et al. | β | 2014 | β |
| Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. | Gong XD et al. | β | 2013 | β |
| On the role of genetic testing for personalized drug overdose management. | Manini A et al. | β | 2013 | β |